Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 7
2007 3
2008 3
2009 6
2010 8
2011 5
2012 5
2013 10
2015 3
2016 4
2017 2
2018 1
2020 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 20728698

61 results

Results by year

Filters applied: . Clear all
Page 1
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.
Kerkelä R, Grazette L, Yacobi R, Iliescu C, Patten R, Beahm C, Walters B, Shevtsov S, Pesant S, Clubb FJ, Rosenzweig A, Salomon RN, Van Etten RA, Alroy J, Durand JB, Force T. Kerkelä R, et al. Nat Med. 2006 Aug;12(8):908-16. doi: 10.1038/nm1446. Epub 2006 Jul 23. Nat Med. 2006. PMID: 16862153 Free article.
Therapeutic protein kinase inhibitors.
Grant SK. Grant SK. Cell Mol Life Sci. 2009 Apr;66(7):1163-77. doi: 10.1007/s00018-008-8539-7. Cell Mol Life Sci. 2009. PMID: 19011754 Review.
Role of tyrosine kinase inhibitors in cancer therapy.
Arora A, Scholar EM. Arora A, et al. J Pharmacol Exp Ther. 2005 Dec;315(3):971-9. doi: 10.1124/jpet.105.084145. Epub 2005 Jul 7. J Pharmacol Exp Ther. 2005. PMID: 16002463 Review.
Another look at imatinib mesylate.
Strebhardt K, Ullrich A. Strebhardt K, et al. N Engl J Med. 2006 Dec 7;355(23):2481-2. doi: 10.1056/NEJMcibr065325. N Engl J Med. 2006. PMID: 17151370 No abstract available.
61 results